# FDA Inspection 1155311 - Cleveland Clinic South Pointe - October 20, 2021

Source: https://www.keypedia.com/records/fda_inspections/cleveland-clinic-south-pointe/4bc2ff24-e558-4128-8d9b-c35e229fd2cb
Source feed: FDA_Inspections

> FDA Inspection 1155311 for Cleveland Clinic South Pointe on October 20, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155311
- Company Name: Cleveland Clinic South Pointe
- Inspection Date: 2021-10-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1220664 - 2023-10-05](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-south-pointe/0421c5ea-840d-47b1-a18b-ca96d9aaaca0)
- [FDA Inspection 1155311 - 2021-10-20](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-south-pointe/37f7c066-ca01-4a7b-ba3b-f4953158fc28)
- [FDA Inspection 853123 - 2013-10-29](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-south-pointe/912debd2-02c5-41ba-b334-38817ae9ae2b)

Company: https://www.keypedia.com/companies/cleveland-clinic-south-pointe/56384fbf-3578-4cd9-901b-6264eea660eb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d